UNASSIGNED: To investigate the effectiveness of endoscopic radical mastectomy for breast cancer combined with total pectoral muscle reconstruction with breast implants.
UNASSIGNED: The clinical data of 138 female patients with breast cancer who met the selection criteria between April 2019 and December 2023 were retrospectively analyzed. The mean age of the patients was 43.8 years (range, 27-61 years). The maximum diameter of the tumors ranged from 1.00 to 7.10 cm, with an average of 2.70 cm. Pathological examination showed that 108 cases were positive for both estrogen receptor and progesterone receptor, and 40 cases were positive for human epidermal growth factor receptor 2. All patients underwent endoscopic radical mastectomy for breast cancer combined with total pectoral muscle reconstruction with breast implants. The operation time, intraoperative blood loss, prosthesis size, and occurences of nipple-areola complex (NAC) ischemia, flap ischemia, infection, and capsular contracture were recorded. The Breast-Q2.0 score was used to evaluate breast aesthetics, patient satisfaction, and quality of life (including the social mental health score, breast satisfaction score, and chest pain score). Patients were divided into two groups based on the time of operation after the technique was implemented: group A (within 1 year, 25 cases) and group B (after 1 year, 113 cases). The above outcome indicators were compared between the two groups. Furthermore, based on the postoperative follow-up duration, patients were classified into a short-term group (follow-up time was less than 1 year) and a long-term group (follow-up time was more than 1 year). The baseline data and postoperative Breast-Q2.0 scores were compared between the two groups.
UNASSIGNED: The average operation time was 120.76 minutes, the average intraoperative blood loss was 23.77 mL, and the average prosthesis size was 218.37 mL. Postoperative NAC ischemia occurred in 21 cases (15.22%), flap ischemia in 30 cases (21.74%), infection in 23 cases (16.67%), capsular contracture in 33 cases (23.91%), and prosthesis removal in 2 cases (1.45%). The operation time of group A was significantly longer than that of group B ( P<0.05), and there was no significant difference in intraoperative blood loss, prosthesis size, and related complications between the two groups ( P>0.05). All patients were followed up 3-48 months (mean, 20 months). There were 33 cases in the short-term group and 105 cases in the long-term group. There was no significant difference in baseline data such as age, body mass index, number of menopause cases, number of neoadjuvant chemotherapy cases, number of axillary lymph node dissection cases, breast cup size, degree of breast ptosis, and postoperative radiotherapy constituent ratio between the two groups ( P>0.05). At last follow-up, the breast satisfaction score in the patients\' Breast-Q2.0 score ranged from 33 to 100, with an average of 60.9; the social mental health score ranged from 38 to 100, with an average of 71.3; the chest pain score ranged from 20 to 80, with an average of 47.3. The social mental health score of the long-term group was significantly higher than that of the short-term group ( P<0.05); there was no significant difference in breast satisfaction scores and chest pain scores between the two groups ( P>0.05). No patient died during the follow-up, and 2 patients relapsed at 649 days and 689 days postoperatively, respectively. The recurrence-free survival rate was 98.62%.
UNASSIGNED: Endoscopic radical mastectomy for breast cancer combined with total pectoral muscle reconstruction with breast implants has fewer complications and less damage, and the aesthetic effect of reconstructed breast is better.
UNASSIGNED: 探讨腔镜下乳腺癌根治术并全胸肌后乳房植入物重建的临床效果。.
UNASSIGNED: 回顾分析2019年4月—2023年12月收治且符合选择标准的138例女性乳腺癌患者临床资料。患者年龄27~61岁,平均43.8岁;肿瘤最长径1.00~7.10 cm,平均2.70 cm。病理学检查示雌激素受体阳性108例,孕激素受体阳性108例,人表皮生长因子受体2阳性40例。均行腔镜下乳腺癌根治术并全胸肌后乳房重建手术治疗。记录患者手术时间、术中出血量、假体大小,以及乳头乳晕复合体(nipple-areola complex,NAC)缺血、皮瓣缺血、感染及包膜挛缩等情况;使用Breast-Q2.0评分量表行乳房美学、满意度及生活质量评估(包括乳房满意度评分、社会心理健康评分和胸部疼痛评分)。根据该技术开展后实施手术的时间,将患者分为第1年内手术组(A组25例)和1年后手术组(B组113例),比较两组上述结局指标;根据术后随访时间将患者分为短期组(随访时间<1年)和长期组(随访时间≥1年),比较两组基线资料及术后Breast-Q2.0评分。.
UNASSIGNED: 患者手术时间平均120.76 min,术中出血量平均23.77 mL,假体大小平均218.37 mL。术后发生NAC缺血21例(15.22%),皮瓣缺血30例(21.74%),感染23例(16.67%),包膜挛缩33例(23.91%),假体取出2例(1.45%)。除A组手术时间显著长于B组( P<0.05)外,两组术中出血量、假体大小及相关并发症发生情况比较差异均无统计学意义( P>0.05)。所有患者均获随访,随访时间3~48个月,平均20个月;其中短期组33 例,长期组105 例,两组患者年龄、身体质量指数、绝经例数、新辅助化疗例数、腋窝淋巴结清扫例数、乳房罩杯、乳房下垂程度及术后放疗构成比等基线资料比较差异均无统计学意义( P>0.05)。末次随访时,患者Breast-Q2.0评分中乳房满意度评分为33~100分,平均60.9分;社会心理健康评分为38~100分,平均71.3分;胸部疼痛评分为20~80分,平均47.3分。其中长期组患者社会心理健康评分高于短期组( P<0.05);两组乳房满意度评分及胸部疼痛评分比较差异无统计学意义( P>0.05)。随访期间无患者死亡,2例患者分别于术后649 d和689 d复发;无复发生存率为98.62%。.
UNASSIGNED: 腔镜下乳腺癌根治术并全胸肌后乳房植入物重建术损伤小、术后并发症少,重建后的乳房美学效果较好。.